Home > Compound List > Product Information
Gleevec-d8 Mesylate (Imatinib-d8 Mesylate)_Molecular_structure_CAS_)
Click picture or here to close

Gleevec-d8 Mesylate (Imatinib-d8 Mesylate)

Catalog No. G407002 Name Toronto Research Chemicals
CAS Number Website http://www.trc-canada.com
M. F. C30H35N7O4S Telephone +1 (416) 665-9696
M. W. 589.7084 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage Hygroscopic, -20°C Freezer, Under Inert Atmosphere Chembase ID: 169639

SYNONYMS

IUPAC name
4-{[4-methyl(2H8)piperazin-1-yl]methyl}-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; methanesulfonic acid
IUPAC Traditional name
4-{[4-methyl(2H8)piperazin-1-yl]methyl}-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; methanesulfonic acid
Synonyms
CGP 57148B-d8
Imatinib-d8 Mesilate
Gleevac-d8
Imatinib-d8 Mesylate
4-[(4-Methyl-1-piperazinyl-d8)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Methanesulfonate
Glivec-d8
STI 571-d8

DATABASE IDS

PROPERTIES

Certificate of Analysis Download
Apperance Yellow Solid
Melting Point 148-150°C
Solubility Chloroform
Solubility DMSO
Solubility Methanol
MSDS Link Download
Storage Condition Hygroscopic, -20°C Freezer, Under Inert Atmosphere

DETAILS

Description (English)
A deuterated tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL).

REFERENCES

  • Schindler, T., et al.: Science, 289, 1938 (2000)
  • Drucker, B.J., et al.: N. Engl. J. Med., 344, 1031 (2000)